Catalent Pharma Solutions

As the originator of the RP Scherer softgel rotary-die process, Catalent has more than 80 years’ manufacturing experience in the formulation and delivery of pharmaceutical and consumer softgels. Catalent continues to innovate, with specialised global manufacturing and technological enhancements, such as chewable softgels; enteric coatings to enable delayed-release of the active ingredient with targeted absorption; its breakthrough softgel technologies such as OptiShell™, a plant-derived capsule suitable for complex fill formulations; OptiGel™ Bio for macromolecules; and OptiGel™ Lock designed for abuse deterrence. To support its growing customer base in the region, Catalent has made substantial investments in two joint ventures in China. Recently, the company celebrated its 40th year in Japan with a new, dedicated laboratory to provide proof-of-concept support and feasibility studies for Catalent’s proprietary Zydis® Orally Dispersible Tablet technology, which is used in over 20 products in 50 countries worldwide and enables fast-dissolve formulations of dose forms, in as little as three seconds. Investment has also been made in Japan to support the expansion of manufacturing capacity for its OptiGel Micro™ softgel technology. www.catalent.com

---

---